| FFAI 0.5319 85.52% | BYND 1.045 -9.91% | CTNT 0.0445 -18.80% | FCHL 0.2835 26.00% | TZA 5.14 2.90% | LOBO 0.6848 19.59% | ASBP 0.1968 -24.86% | BURU 0.2602 30.10% | RPGL 0.7163 59.21% | BITO 10.29 -1.63% | NVDA 199.88 -1.08% | SOXS 18.2 -2.31% | INTC 66.26 0.85% | TQQQ 57.4 -1.17% | NVTS 15.33 16.14% | BMNG 1.43 -7.74% | PLUG 3.08 -4.35% | LOCL 3.03 61.17% | ONDS 10.87 1.30% | SPDN 9.2 0.66% | OPEN 5.45 1.87% | XRTX 2.69 19.56% | TSLL 12.87 -3.16% | EDBL 0.6896 -25.04% | SQQQ 57.59 1.19% | NVD 5.71 2.15% | AAL 11.77 -3.84% | SOFI 18.83 -3.44% | SOXL 98.09 2.24% | NOK 10.3968 -1.92% | BTG 4.72 -4.45% | HIMS 29.76 -4.03% | SPY 704.08 -0.65% | HYG 80.37 -0.26% | POET 10.25 19.32% | SNAP 5.65 -5.83% | SOUN 7.85 -5.65% | NFLX 92.58 -2.37% | TOVX 0.3387 -17.39% | SCO 7.59 -5.52% | TSLA 386.42 -1.55% | SLNH 1.31 -6.43% | AAPL 266.17 -2.52% | SOWG 0.1672 -30.30% | LCID 7.11 5.33% | SMR 11.67 -8.76% | GRAB 4.08 -3.09% | PLTR 145.97 0.05% | AMZN 249.91 0.66% | SIDU 3.75 -13.59%

Recent Market Trends Highlight Top Gainers

In recent market trends, several companies have emerged as top gainers, showcasing significant price movements and trading volumes. AMTD Digital Inc. (NYSE:HKD) leads with a 93.49% price increase to $3.27, driven by a trading volume of approximately 286.36 million. This surge is supported by a remarkable 1,085.9% revenue increase for the six months ending April 30, 2025, following the consolidation of The Generation Essentials Group as a subsidiary since October 2024, as highlighted by the company.

Beneficient (NASDAQ:BENF) experienced a 57.18% increase in its stock price to $0.87, with a trading volume of over 113.62 million. The company has regained compliance with Nasdaq's periodic filing and market value requirements, which may have contributed to the heightened investor interest. However, Beneficient still needs to address the $1.00 per share bid price requirement to avoid delisting.

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) saw a 50.69% increase in its stock price to $2.18, with a trading volume of over 31.48 million. The company is set to present preclinical data on its innovative RaniPill® capsule at ObesityWeek® 2025, which may have fueled investor interest in its innovative healthcare solutions.

YD Bio Limited Warrants (YDESW) experienced a 47.06% increase in its stock price to $1.5, despite a smaller trading volume of 22,699. The company's focus on detection and therapeutic technologies has shown promising growth potential, attracting investor attention.

These movements reflect a dynamic market environment, with investors showing keen interest in companies across various sectors. The significant price changes and trading volumes highlight the market's responsiveness to company developments, investor sentiment, and broader economic factors.

Published on: October 31, 2025